WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today regarding CMS’s ruling that certain continuous glucose monitors (CGMs) approved by FDA for making diabetes treatment decisions are considered durable medical equipment and are eligible to be covered by Medicare:
Press Release | January 13, 2017
Press Release | January 12, 2017
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation in the U.S. Senate to permanently repeal the medical device excise tax:
Press Release | January 10, 2017
WASHINGTON, D.C. – Medical technology companies are leveraging the 2015 suspension of the medical device excise tax to expand their businesses and investments, according to a new survey from the Advanced Medical Technology Association (AdvaMed).
February 8, 2017 | Virtual
This webinar will walk the audience through clinical quality, economic value, and data sources. This will include a look at how healthcare reform is changing the focus of healthcare with the... Read More
February 21, 2017 to February 22, 2017| Bogotá, Colombia
Para ver el evento en español, haga clic aquí. We are excited to announce the 2017 Latin America Compliance Conference, scheduled for February 21st-22nd, 2017 and the AdvaMed-ANDI Joint Distributor... Read More
Medical technology aids in the prevention, diagnosis and treatment of various conditions to enhance quality of life and help you enjoy more of life's precious moments.
The Journal Gazette
From artificial joints to replacement heart valves, hospital beds to radiation therapies, the economic and human impact of medical technology innovation cannot be overstated. Medical technology companies that innovate quickly and at high levels of quality create and sustain well-paying jobs and, most importantly, save and improve the lives of patients. And that is why permanent repeal of the medical device tax must be a priority for the 115th Congress in 2017. The 2.3 percent excise tax on...
Tax reform and health care reform are likely to be on the agendas of both the incoming Trump administration and the 115th Congress. Promoting medical innovation should be a national priority, as well. And that is why permanent repeal of the medical device tax must be a priority.
Salt Lake Tribune
In an undeniable victory for patients and medical innovation, last month Congress passed historic legislation known as the 21st Century Cures Act. When fully implemented, this legislation will help accelerate the discovery, development and delivery of medical advancements to ensure more timely access to new treatments and cures for patients in need. Passage of the legislation would not have been possible without support from both sides of the political aisle, including U.S. Sen. Orrin Hatch....
Cape Cod Times
Eight years ago, at the age of 18, I reached my goal as a professional BMX athlete. I had won my first pro contest, I had ridden in the X-games for the first time, I was approaching my third year as a professional on the Dew Tour, and I felt as though I was on top of the world. And then my world turned upside down. I hit my head while riding one day and had to get an MRI, which revealed a benign, meningioma brain tumor that had invaded the left side of my brain. It was growing into my brain...
Inova Health System, the giant nonprofit hospital network serving Northern Virginia, is creating a new start-up incubator and investment program focusing on "personalized" medicine innovations. Executives say they plan to invest at least $100 million over the next three to five years making $2 million to $5 million bets on promising young companies with products that have gained some traction in the marketplace. "We want to create an environment that makes health sciences a new destination, a...